Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

Re: Pensions Scheme

26 Mar 2013 14:45

RNS Number : 9246A
Renold PLC
26 March 2013
 



Renold plc

("Renold" or "the Company" or "the Group")

 

Proposed UK pension scheme merger and future funding

 

Renold, a leading international supplier of industrial chains and related power transmission products, today announces that it has reached agreement with the Trustees of the UK defined benefit pension schemes to merge the schemes and put in place a new long term funding plan.

 

Scheme merger

Agreement has been reached to merge the three closed UK defined benefit pension schemes into one and to wind up the other two schemes. The merger will lead to a significant reduction in administration costs of approximately £0.5m per annum. The merger and wind up process itself is expected to be substantially complete during the first half of the next financial year.

 

Future funding basis

The merged UK pension funds will be underpinned by a 25 year asset backed partnership structure which will provide annual cash contributions of £2.5m to the pension fund, with annual increases linked to RPI and capped at 5%. The present value of this funding stream will be fully recognised as a pension fund asset in the accounts of the merged scheme and will remove £40.0m of the funding basis deficit (estimated at £63m in January 2013). The new arrangement replaces all other existing funding arrangements for the UK defined benefit schemes.

 

Impact on the Group

The underlying reduction in cash administration costs is expected to be £0.5m per annum. In order to support further investment in the business, the Trustees have also agreed to pay the first £0.5m of the remaining expenses (the Company will fund any excess each year). The expected net impact of the agreed changes is therefore a reduction in the Company's annual cash costs of £1.0m. In the first year this will be partially offset by the partnership set up costs and the costs of executing the merger itself.

 

A reduction in the gross pension assets and liabilities reported in the Group's consolidated accounts is expected once the merger is complete. However, the £40.0m asset recognised in the accounts of the merged scheme is not expected to be recognised in the Group's consolidated accounts. The new arrangements are also not expected to have a substantive net impact on the Group's tax position.

 

Robert Purcell, Chief Executive of Renold, commented:

 

"The merger of the schemes will deliver a real reduction in annual cash funding of £1.0m. The support of the UK Trustees will allow us to fund additional investment in the business and will help the new management team to deliver long term and sustainable improvement in the Group's performance for the benefit of all of our stakeholders."

 

26 March 2013

 

 

ENQUIRIES:

 

Renold plc

Tel: 0161 498 4500

Robert Purcell, Chief Executive Officer

Brian Tenner, Finance Director

Arden Partners (Broker)

Tel: 020 7614 5917

Chris Hardie

College Hill (Public Relations)

Mark Garraway

Helen Tarbet

Tel: 020 7457 2020

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on their website at: www.renold.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALDKALLDEFF
Date   Source Headline
12th Jul 20237:00 amRNSResults for the year ended 31 March 2023
10th Jul 20237:00 amRNSInvestor Presentation
19th Jun 20239:30 amRNSBlock Listing Six Monthly Return
18th May 20237:00 amRNSPreference Stock Dividend
9th May 20237:00 amRNSExtension of banking facilities
3rd May 202311:09 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update and Notice of Results
28th Mar 202312:53 pmRNSHolding(s) in Company
9th Mar 20237:00 amRNSNotice of Capital Markets Day
23rd Feb 202312:09 pmRNSHolding(s) in Company
10th Feb 20232:07 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSTrading Update
25th Jan 202310:00 amRNSHolding(s) in Company
24th Jan 20233:09 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSContract Win
19th Dec 20227:00 amRNSBlock Listing Six Monthly Return
8th Dec 20227:00 amRNSHolding(s) in Company
24th Nov 20225:18 pmRNSPreference Stock Dividend
16th Nov 20227:00 amRNSInterim Results
3rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
12th Oct 20229:12 amRNSHolding(s) in Company
5th Oct 20224:10 pmRNSHolding(s) in Company
20th Sep 202212:34 pmRNSGrant of Options
9th Sep 202211:37 amRNSDirector/PDMR Shareholding
6th Sep 202212:13 pmRNSResult of AGM
6th Sep 20227:00 amRNSAGM Trading Update
4th Aug 20227:30 amRNS2022 Annual Report & Notice of AGM
4th Aug 20227:00 amRNSAcquisition of Industrias YUK S.A.
13th Jul 20227:00 amRNSFinal results for the year ended 31 March 2022
8th Jul 20227:00 amRNSInvestor presentation
17th Jun 20227:00 amRNSBlock Listing Six Monthly Return
18th May 202212:18 pmRNSPreference Stock Dividend
4th May 20227:00 amRNSAppointment of Non-Executive Director
19th Apr 20223:53 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Update and Notice of Results
2nd Feb 20224:35 pmRNSPrice Monitoring Extension
25th Jan 20229:23 amRNSHolding(s) in Company
20th Jan 20224:42 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
20th Dec 202111:10 amRNSHolding(s) in Company
17th Dec 20218:43 amRNSBlock Listing Six Monthly Return
29th Nov 20213:15 pmRNSHolding(s) in Company
10th Nov 20217:00 amRNSInterim Results
8th Nov 20217:00 amRNSPreference Stock Dividend
5th Nov 20217:00 amRNSAppointment of Joint Broker
2nd Nov 202111:07 amRNSHolding(s) in Company
1st Nov 20211:04 pmRNSHolding(s) in Company
27th Oct 20217:00 amRNSNotice of Interim Results
20th Oct 20213:48 pmRNSHolding(s) in Company
31st Aug 202111:50 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.